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Abstract
Human influenza A viruses undergo antigenic changes with gradual accumulation of amino acid substitutions on the
hemagglutinin (HA) molecule. A strong antigenic mismatch between vaccine and epidemic strains often requires the
replacement of influenza vaccines worldwide. To establish a practical model enabling us to predict the future direction of
the influenza virus evolution, relative distances of amino acid sequences among past epidemic strains were analyzed by
multidimensional scaling (MDS). We found that human influenza viruses have evolved along a gnarled evolutionary
pathway with an approximately constant curvature in the MDS-constructed 3D space. The gnarled pathway indicated that
evolution on the trunk favored multiple substitutions at the same amino acid positions on HA. The constant curvature was
reasonably explained by assuming that the rate of amino acid substitutions varied from one position to another according
to a gamma distribution. Furthermore, we utilized the estimated parameters of the gamma distribution to predict the
amino acid substitutions on HA in subsequent years. Retrospective prediction tests for 12 years from 1997 to 2009 showed
that 70% of actual amino acid substitutions were correctly predicted, and that 45% of predicted amino acid substitutions
have been actually observed. Although it remains unsolved how to predict the exact timing of antigenic changes, the
present results suggest that our model may have the potential to recognize emerging epidemic strains.
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Introduction
The hemagglutinin (HA) molecule of influenza A viruses is the
prime target of antibodies that neutralize viral infectivity. The
strong immune pressure against HA in the human population
selects a new variant every 2–5 years [1–6]. Thus influenza A
viruses undergo antigenic changes with gradual accumulation of
amino acid substitutions on HA, and the antigenic change is one of
the primary reasons why vaccination is not a perfect measure to
control seasonal influenza. Accordingly, influenza vaccine often
requires replacement to avoid antigenic mismatch between
vaccine and epidemic strains [7]. The decision of vaccine
replacement must be made several months before a minor strain
become dominant strain [8]. Thus the prediction of antigenic
change of influenza A virus [2,9–15] has been one of the major
public health goals.
Phylogenetic analyses of HA genes of human H3N2 viruses
have revealed the presence of a long main trunk and short side
branches in their evolutionary tree. The main trunk has grown
continuously from a pandemic strain in 1968 to recent epidemic
strains, and tips of each branch reached a dead end on the
evolutionary pathway [13,14,16–18]. This ‘cactus-like’ phyloge-
netic tree indicates that the viruses on the side branches do not
produce next epidemic strains, while the viruses near the main
trunk do contribute to the production of both an epidemic strain
and its next epidemic strain. Although two or more antigenically
different strains were known to co-circulate in a single epidemic
season [13,19,20], the single-trunk phylogenetic tree indicates the
diversity of the HA amino acid sequences at any point in time is
relatively limited. The reason why only one trunk exists has yet to
be fully understood, but several theories have been proposed to
explain this phenomenon [21–23].
The aims of the present studies are to establish a practical model
enabling us to predict the evolutionary direction of the virus that
causes future epidemics and to examine the accuracy of the
prediction based on the model. First we analysed relative distances
of amino acid sequences among past epidemic strains using a
method called multidimensional scaling (MDS) [24]. We found
that human influenza viruses have evolved along a gnarled
evolutionary pathway with an approximately constant curvature in
the MDS-constructed 3D space. The constant curvature was
reasonably explained by assuming that the rate of amino acid
substitutions varied from one position to another according to a
gamma distribution. The estimated parameters of the gamma
PLoS ONE | www.plosone.org 1 October 2011 | Volume 6 | Issue 10 | e25953distribution allowed us to predict the amino acid substitutions on
HA in subsequent years with reasonable accuracy, indicating the
potential to select suitable vaccine strains for the subsequent
epidemic seasons.
Results
To expose underlying patterns of HA amino acid substitutions
in the evolutionary pathway along the main trunk, we conducted
multidimensional scaling (MDS) analysis [24] of HA sequences.
The fundamental idea for visualizing a large number of sequences
in a low dimensional space is based on the same idea described in
a recent paper by He and Deem [15]. By performing MDS
analysis, one may obtain a visual map of objects where the
dissimilarity between objects is represented as the distance
between corresponding points. A total of 2,640 unique amino
acid sequences of the HA1 [3,25] domain (328 amino acids long)
of the H3N2 viruses isolated from humans during the period from
1968 through 2009 were analysed by MDS and visualized in a
three-dimensional (3D) space (Figure 1, Movie S1). In the resulting
3D map, each HA sequence was represented as a point, and the
number of different amino acids between two HA sequences was
represented as the relative distance between two corresponding
points. Although the original amino acid sequences provided 328
dimensional data, the numbers of different amino acids among
sequences were reasonably approximated by distance in this 3-
dimensional map with a root-mean-square error of 1.72 (Figure
S1). Consistent with phylogenetic analyses, viruses that were
isolated close in time were located near each other, forming a thick
main trunk with short branches elongated from the trunk
(Figure 1A, Figure 1B). The main trunk grew continuously from
a pandemic strain in 1968 to recent epidemic strains. Each branch
consisted of epidemic strains isolated during a period of 3–5 years.
It should be noted that the MDS representation revealed a
characteristic feature that has not been clear only from
phylogenetic trees, the observation of a gnarled trunk constantly
curved in the 3D map. Since amino acid substitutions on human
virus HA mainly occur in the HA1 domain [3], this result
indicated that the evolution of H3N2 virus HA was characterized
by this gnarled evolutionary pathway.
We also conducted the same analysis for H1N1 human viruses
(Figure S2, Movie S2). The 3D representation of HA sequences of
H1N1 seasonal influenza viruses showed the same pattern in their
evolutionary pathways, a long gnarled trunk elongated from the
pandemic strain in 1918. Another H1N1 pandemic strain, which
was introduced into the human population in 2009 [26], was
located at the end of a step-wise path that consisted of swine H1N1
influenza viruses isolated from humans from 1976 to 2007 [27].
In the 3D map in Figure 1, the spatial distance between each
pair of sequences represents the number of different amino acids
between these sequences. Figure 2 illustrates two distinct patterns
of amino acid substitutions that produce different spatial
arrangements of viruses in this map. If a series of amino acid
substitutions all occur in different positions, then the distance from
an ancestor to a mutant should be proportional to the number of
substitutions. These independent substitutions make a straight
arrangement of viruses on the map (Figure 2A, 2B). On the other
hand, if amino acids at particular positions were substituted more
than once, the distance from an ancestor to a mutant should be
less than the number of substitutions. These concentrated
substitutions at the same amino acid positions make a curved
arrangement of viruses (Figure 2C, 2D). For this reason, the
gnarled trunk found in the MDS representation of HA sequences
(Figure 1) indicated that HA variants on the trunk favoured
multiple amino acid substitutions at the same positions. The fact
that most of the amino acid substitutions occurred near antigenic
domains A–E [3,5,9,28] was consistent with the observation of the
curved trunk in the 3D map.
To investigate the property of the curvature of the main trunk,
we analysed the distribution of the number of positions that were
substituted on the trunk from 1968 to 2009 (Figure 3A, Table S1).
Of the 328 positions on the HA1 sequence, 260 remained
unchanged for 41 years. At 36 amino acid positions, residues were
substituted once, and at 19 positions twice. The number of
positions gradually decreased as their observed frequency of
substitutions increased, but there was one position that has
substituted eight times. The mean of the substitution frequencies
was 0.384, and the variance of the substitution frequencies was
0.904. Given these statistics for the substitution frequency, the
shape of the histogram is almost identical to the curve of a gamma
distribution [29] having the same mean and variance (Figure 3A).
From this result, it is likely that the rate of amino acid substitutions
varies from one position to another according to a gamma
distribution.
To estimate the parameters of the gamma distribution precisely,
non-linear regression analysis was performed. First, 91 HA
sequences near the main trunk were selected as trunk sequences.
In Figure 3B, the number of different amino acids between two
trunk sequences (Figure 3C) is plotted against the difference in
their isolation years. It is known that if the amino acid substitution
rate varies according to a gamma distribution, the expected
number of different amino acids between two sequences can be
calculated by the formula: d~L(1{(a=(az  r rt))
a), where Lis the
length of the sequences, a is the shape parameter of the gamma
distribution (gamma parameter),   r r is the mean substitution rate,
and t is the difference in the years of the two sequences [30]. By
fitting the above formula to the actual numbers of different amino
acids on the trunk, the gamma parameter and mean substitution
rate were estimated (a=0.129 and   r r=0.0118), showing a good fit
to the actual data (P,0.001). This result indicated that the number
of different amino acids between two sequences could be
determined from the difference of the year of isolation, according
to the gamma-distribution-based model presented above. Thus, it
is reasonable to conclude that the constant curvature on the trunk
in the MDS representation (Figure 1) was attributed to this nature.
Next, an attempt was made to apply the gamma-distribution-
based substitution model of the trunk to the prediction of amino
acid substitutions in subsequent years. The key idea of our
prediction method is to select the direct progenitor virus for future
epidemics from the surveillance samples of each year. We
designate a virus strain that is located near the trunk extending
into the next year as a Leading Bud. A Leading Bud can be
considered as an potential dominant strain that is not dominant in
the given year and become dominant the next year [15]. Using the
formula d~328|(1{(a=(az  r rt))
a)under the estimated aand   r r,
one may calculate the expected number of different amino acids
between two HA sequences located on the trunk. According to this
gamma-distribution-based formula, a virus that will appear on the
trunk in a particular year is expected to have 4, 7, 10, 13, ... , 60
different amino acids in HA, when compared with viruses in 1, 2,
3, 4, ... , 42 years before, respectively. Therefore, given the large
variety of viruses isolated in a year, the virus that is likely to be
located near the extended trunk is the virus to which HA sequence
dissimilarities from past viruses have the highest fit to those
expected under the gamma-distribution-based formula (Figure3D).
To examine whether the method correctly selected the Leading
Bud in the subsequent year, we conducted retrospective tests for
each year from 1997 to 2009. Evaluation was made by comparing
An Evolutionary Model of H3N2 Influenza A Virus
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subsequent year, which consisted of the amino acids that
constituted the majority at each position in the year. Table 1
shows the results of retrospective tests (for details, see Table S2).
The recall, which is the probability that an actual substitution was
correctly predicted, was 1.00 in 4 of the 12 calendar years. The
overall recall of the prediction was 0.70, indicating that the model
had a reasonable ability to predict amino acid substitution in the
subsequent year for each year. The precision, which is the
probability that a predicted substitution actually occurred, varied
from 0.0 to 0.89, and the overall recall of the prediction was 0.45.
To assess the validity of the result of the retrospective tests, we
repeated similar retrospective tests with other methods and
compared the results (Table 2). First we tested a method that
randomly selects an HA sequence for each year. With 100 sets of
tests, overall precision and recall were 0.2460.015 and
0.2260.012 respectively, showing low predictive ability as
expected. Secondly we tested method that selects the HA sequence
that has the maximum numbers of substitutions at the 18 positively
selected codons identified by Bush et al [10]. Although the overall
precision and recall were much higher than random tests, the
accuracy of prediction was lower than that of our method. Three
methods that select the sequence that has the maximum number of
amino acid substitutions from current and past dominant
sequences yielded higher recalls. However, the overall precision
was lower than the method using 18 positively selected codons.
Among all the methods we tested, the gamma-distribution-based
method was the only method that yields higher recall and higher
precision than Bush’s methods.
Discussion
Our study found that the long-term evolution of HA was
reasonably characterised by a ‘bonsai-like’ pathway of which trunk
Figure 2. Two distinct patterns of amino acid substitutions that produce different spatial arrangements of viruses. (A) The straight
arrangement of viruses. If a series of amino acid substitutions all occur in different positions, then the distance from an ancestor to a mutant should
be proportional to the number of substitutions (B). These independent substitutions make a straight arrangement of viruses on the map. (C) The
curved arrangement of viruses. If amino acids at particular positions were substituted more than once, the distance from an ancestor to a mutant
should be less than the number of substitutions (D). These concentrated substitutions at the same amino acid positions make a curved arrangement
of viruses. In both panels, viruses are represented by circles, with illustrative examples of their amino acid sequences and substitutions on them.
doi:10.1371/journal.pone.0025953.g002
Figure 1. Three-dimensional map of HA sequences of H3N2 human influenza A viruses. A total of 2,640 amino acid sequences of the HA1
domain of human H3N2 influenza A viruses isolated during the period from 1968 through 2009 are visualized in a 3D space. Each point represents a
virus strain. The distance between two viruses in the 3D map represents the number of different amino acids between their HA sequences. The whole
coordination is determined by MDS analysis. The root-mean-square error of the 3D map was 1.72. All three axes represent the sequence dissimilarity
(spacing between grid lines represents 10 different amino acids), and the configuration can be freely rotated and translated. Shadows represent
projections of points onto the coordinate planes. (A) the 3D map colour-coded by the year of isolation of the virus. (B) a schematic diagram of the 3D
map.
doi:10.1371/journal.pone.0025953.g001
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unique property of the sequence evolution indicated that the
evolution on the trunk favoured multiple substitutions at the same
positions on HA molecules. Our study found that the curvature
was relatively constant and reasonably explained by assuming that
the rate of amino acid substitutions on HA varied from one
position to another according to a gamma distribution. The
estimated parameters of the gamma distribution allowed us to
predict the amino acid substitutions on HA in subsequent years
with reasonable accuracy.
The small value of its gamma parameter estimated in this study
suggested that most of amino acids on HA remained unchanged,
Figure 3. The amino acid substitutions on the gnarled trunk. (A) the distribution of the number of positions that were substituted on the
trunk from 1968 to 2009. The gamma distribution that has a mean substitution frequency of 0.418 and a variance of 1.155 is superimposed. (B) The
number of different amino acids between the trunk sequences plotted against the difference in their isolation years. The horizontal bars indicate
mean values, and vertical lines indicate 61 standard deviation of the number of different amino acids. A non-linear regression curve using the
formula d~328|(1{(a=(az  r rt))
a) is superimposed (a=0.129,   r r=0.0118), showing good fit to the actual data (P,0.001). (C) A schematic illustration
of trunk viruses and the sequence dissimilarities among them. A trunk virus is a virus located near the main trunk. Circles labelled with t0,...,t6 are
examples of trunk viruses. The sequence dissimilarities among trunk sequences are shown by solid lines. (D) The selection of a Leading Bud. Using the
formula of d~328|(1{(a=(az  r rt))
a), one may calculate the expected sequence dissimilarities between a future trunk virus and past trunk viruses
(dotted lines). The bold arrow indicates a candidate for Leading Buds. For the coming influenza season in 2010, A/Thailand/CU-B110/2009(H3N2) was
predicted to be the most likely candidate virus (Table S2).
doi:10.1371/journal.pone.0025953.g003
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number of positions on the HA. The result was consistent with
previous studies identifying several positions that had undergone
the positive Darwinian selection, where non-synonymous muta-
tions have been favoured [16,17,28,31,32]. Although the positions
that undergo amino acid substitutions could have been moving to
different positions over time [33], our analysis indicated that the
relative sequence distance between two trunk sequences remained
roughly constant with respect to the difference in their isolation
years. This stable feature allowed us to predict the relative
sequence distance between two viruses located on the trunk, and
led us a fully-computerized prediction method.
He and Deem have recently pointed out that an MDS
visualization with density estimation allowed us to identify a
cluster of ‘incipient dominant strains’ before it became dominant
[15]. They proposed two important criteria for the selection of a
new vaccine strain. The first criterion is that a new cluster that
does not contain currently circulating strains or vaccine strains is
detected. The second criterion is that the current vaccine strain
does not provide high protection against strains in the new cluster.
The reason why our gamma-distribution-based model achieves
high recall and precision can be explained by their two criteria.
First of all, the recognition of a Leading Bud conceptually
corresponds to the detection of a newly emerging cluster of
incipient dominant strains. Since a Leading Bud described in this
paper should have a certain amount of different amino acids from
dominantly circulating strains, a Leading Bud can be considered
as one of the early isolates in a newly emerging cluster. Although
we do not consider whether Leading Buds form a cluster or not,
this property partially fits their first criterion. Secondly, our
gamma distribution-based method recognizes a Leading Bud by
finding an HA sequence that has the amino acid substitutions at
the same positions as those seen in the past evolution. Since most
of past amino acid substitutions are concentrated in the antigenic
sites (Table S1), it is highly likely that the Leading Bud having
amino acid substitutions at these positions antigenically differ from
the dominantly circulating strain and the vaccine strain. This
could meet the second criterion.
The overall recall of our prediction method was around 0.70,
indicating that the model had a reasonable ability to predict amino
acid substitution in the subsequent year for each year. It should be
noted that this high recall was achieved by the prediction method
that relied only upon the number of different positions in the
amino acid sequences and the isolation year of the viruses. The
overall precision, on the other hand, was around 0.45. Some of
mistaken predictions might be attributable to the delayed
Table 1. Results of retrospective tests for the prediction of amino acid substitutions.
Test Year
The number of
predicted substitutions
The number of
actual substitutions
The number of correctly
predicted substitutions Recall Precision
1998 9 8 8 1.00 0.89
1999 4 3 1 0.33 0.25
2000 4 5 2 0.40 0.50
2001 10 5 5 1.00 0.50
2002 7 3 1 0.33 0.14
2003 13 12 11 0.92 0.85
2004 4 5 3 0.60 0.75
2005 2 0 0 - 0.00
2006 4 2 2 1.00 0.50
2007 5 2 0 0.00 0.00
2008 4 1 0 0.00 0.00
2009 7 1 0 0.00 0.00
overall 73 47 33 0.70 0.45
Recall was defined as the number of correctly predicted substitutions divided by the total number of actual substitutions. Precision was defined as the number of
correctly predicted substitutions divided by the total number of predicted amino acid substitutions.
doi:10.1371/journal.pone.0025953.t001
Table 2. Comparison of overall recall and precision with other methods.
Method Overall Recall Overall Precision
Select a sequence randomly (n=100) 0.2260.012 0.2460.015
Select the one that has the maximum numbers of substitutions at the 18 codons identified by Bush et al 0.49 0.34
Select the one that has the maximum numbers of substitutions from the current dominant sequence 0.51 0.13
Select the one that has the maximum numbers of substitutions from past dominant sequences 0.55 0.25
Select the one that has the maximum numbers of substitutions from the dominant sequence of two years ago 0.70 0.23
Select the one that has the maximum numbers of substitutions at antigenic domains A–E 0.70 0.32
Select the one that has the minimum errors from the gamma-distribution-based expectation 0.70 0.45
doi:10.1371/journal.pone.0025953.t002
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on the trunk. For instance, the predicted substitutions for I144N in
1999, R50G in 2000 and 2001, E83K V202I, W222R G225D in
2001, and V226I and S227P in 2002 did not occur in the next
years, but rather 2 or 3 years later (Table S2). For these idle
periods, the prediction method could have looked too far ahead,
and the Leading Buds might be too early to be used as vaccine
strains.
In the retrospective tests, we evaluated the prediction methods
by comparing the amino acid sequences of the Leading Buds with
the dominant sequences in subsequent years. It was also confirmed
that WHO-recommended vaccine strains had amino acid residues
that were identical to those predicted by our method (Table S2).
The major difference lies in the timing. We accept that an
overhasty selection of vaccine strains might lead antigenic
mismatch between vaccine and epidemic strains. The prediction
of the exact timing of the antigenic change could become a subject
of future study. In addition to the timing of antigenic change, a
careful investigation on their characteristics such as antigenicity
and growth in embryonated hen eggs must be practically
important for the vaccine selection.
Vaccine strains must be selected in order to match the
antigenicity of viruses that will circulate in the influenza season.
The antigenic cartography, which was developed by Smith et.al,
enables us to accurately predict antigenic similarity between two
virus strains based on a large collection of hemagglutination
inhibition (HI) assay data [5]. In the period from 2005 to 2006, for
instance, the circulating H3N2 viruses changed from A/Califor-
nia/7/2004-like viruses to A/Wisconsin/67/2005-like viruses
[15,34]. The Leading Bud found in 2005 was A/Okinawa/18/
2005. The antigenic-cartography-based antigenic distance be-
tween A/Okinawa/18/2005 and A/Wisconsin/67/2005 was
found to correspond to a twofold difference in HI titers of antisera
[34]. Therefore, it is likely that the antigenicity of A/Okinawa/
18/2005 could match the epidemic strain in 2006. Although the
Leading Buds may not be perfect candidates for the vaccine
strains, we believe that our prediction method could provide useful
information for the formulation of influenza vaccines.
Retrospective tests for 2006–2007, 2007–2008, and 2008–2009
failed to predict the actual amino acid substitutions. The low recall
and precision are likely due to the limited number of amino acid
substitutions during these periods. Since antigenic changes of
H3N2 viruses occur every 3–5 years in a punctuated manner [5],
the conservation of dominant sequences in a few contiguous years
is common in the evolution of H3N2 viruses. We have not taken
such periodicity into account in our evolutionary model, and our
method could not predict the exact timing when a dominant strain
is replaced by another strain. This result highlighted the need to
develop a method that can predict the exact timing of the
antigenic change of the virus. However, the HA of the dominant
H3N2 virus after the September in 2009 possessed 3 of 6 amino
acid substitutions that were predicted by our method using the
sequence data before August 2009 (Table S2). A/Perth/16/2009,
a similar strain to our Leading Bud (A/Thailand/CU-B110/
2009), was recommended as a vaccine strain for H3N2 viruses by
WHO on Dec 1st in 2010.
Further understanding of the gnarled trunk might be achieved
by combined efforts with experimental studies. Future research
direction include the association of the gnarled trunk evolution
with the prediction of antigenic evolution [5,35,36], the effect of
mutations upon biological activity of the protein [37,38], and the
effect of cross immunity to previously circulating dominant strains
[21,22]. Finally, the 3D visualization technique we present here
enables us to represent the direction of sequence evolution as well
as sequence phylogeny, providing additional information that is
not obtained via traditional phylogenetic analysis.
Materials and Methods
Sequence Data
Nucleotide sequences for HA genes of H3N2 influenza A viruses
isolated from humans during the period from 1968 to 2009 were
downloaded from the Influenza Virus Resource at the National
Center for Biotechnology Information (NCBI) [39] on Feb 23 in
2010. The isolation date of the latest sequence was July 11
th 2009.
After eliminating sequences that contained ambiguous nucleotide
codes, 6,806 amino acid sequences of the HA1 domain were
determined by translating the nucleotide sequences using the
standard genetic code. All the amino acid sequences were 328
amino acids long. Nucleotide sequences that gave an identical
amino acid sequence were grouped together, and the nucleotide
sequence having the fewest mutations from the pandemic strain in
1968 was used as a representative. By removing all identical amino
acid sequences except one, 2,640 unique amino acid sequences
were obtained.
MDS analysis
For every pair of the 2,640 amino acid sequences of the HA1
domain, the sequence dissimilarity, which is the total number of
positions where the two sequences possess different amino acids,
was calculated. The resulting 3,483,480 pair-wise dissimilarities
were stored in a dissimilarity matrix. The SMACOF algorithm
[24] was used to find the optimal coordination of all sequences in
the 3D map to minimise the sum of squared errors:
X
s1,s2[HA1
(d(s1,s2){dM(s1,s2))
2,
where s1and s2are sequences of the HA1 domain, d(s1,s2) is the
sequence dissimilarity, dM(s1,s2)is the Euclidean distance in the
3D map.
Amino Acid Substitution on the Trunk
A parsimony tree of HA was constructed from a total of 2,640
nucleotide sequences of the HA1 domain. The dnapars program
in the PHYLIP package
24 was used to construct the parsimony
tree. The main trunk of the tree was defined as the longest path
from the HA of the pandemic strain in 1968 to the HA of a strain
circulating in 2009. The hypothetical nucleotide sequence on each
trunk was translated into an amino acid sequence. For each
residue position of the HA1 domain, amino acid substitutions
found on the trunk were counted, and then the mean and variance
of the substitution frequency were calculated and compared with a
gamma distribution having the same mean and variance.
Substitution Model
When assuming the variation of substitution rates follows
a gamma distribution, the expected sequence distance be-
tween two sequences can be calculated by the formula
d~L(1{(a=(az  r rt))
a), where t is the difference in their isolation
years and L=328 is the length of the HA1 domain. To obtain
non-hypothetical amino acid sequences located near the trunk, a
neighbour-joining tree was constructed from their nucleotide
sequences. The tree construction was done using the dnadist and
neighbor programs in the PHYLIP package [40] with the Jukes-
Cantor distance option. For each trunk node of the neighbour
An Evolutionary Model of H3N2 Influenza A Virus
PLoS ONE | www.plosone.org 7 October 2011 | Volume 6 | Issue 10 | e25953joining tree, the amino acid sequence having shortest path to the
trunk node was selected. Out of 2,640 HA sequences, 91
sequences were selected as trunk sequences (Table S3). For every
pair of these selected sequences, their sequence dissimilarity (d)
and the difference in isolation years (t) was recorded. By fitting the
formula d~L(1{(a=(az  r rt))
a)to the observed relationship be-
tween dand t, the gamma parameter (a) and mean substitution
rate (  r r) for our substitution model were estimated. In order to
estimate the effect of the selection of trunk sequences on the
Figure 3B, we performed a bootstrap resampling analysis. We
made 100 datasets each containing 91 trunk sequences obtained
by random resampling of the original 91 trunk sequences. Then,
errors on the mean number of different amino acids were
estimated using the 100 bootstrap datasets. As shown in the Figure
S3, the errors of the means were estimated to be around one
amino acid, suggesting that the result shown in Figure 3 has
moderate robustness to the selection of trunk sequences.
Dominant sequence
To define a representative sequence for each year, we adopted a
strategy using the majority vote rule. For each year and each
residue position, the dominant amino acid was determined as the
amino acid that constituted the majority at the position in the year.
The dominant sequence of a year was defined as the concatena-
tion of the dominant amino acids of every position in the year.
Prediction and retrospective tests
For each year, a Leading Bud, which is an amino acid sequence
that will be located near the trunk in the next year, was predicted
as follows. Let y be a year. For a future HA sequence sthat would
appear in the year yz1, the expected number of different amino
acids from each past trunk sequence uin year y0 (y{y0§0)can be
denoted by the formula dE(s,u)~L(1{(a=(az  r r(y{y0z1)))
a).
Thus, among sequences isolated in the year y, the sequence that is
most likely to become a Leading Bud in the next year is formulated
as the sequence s0, such that s0 has the least sum of squared errors
between sequence distance and expected distance from each trunk.
The sum of squared errors is calculated by the formula:
X
u[Tƒy
(d(s0,u){dE(s0,u))
2
dE(s0,u)
,
where Tƒy is a set of trunk sequences whose isolation years are
earlier than or equal toy. The amino acid sequence of the
predicted Leading Bud was compared with the dominant sequence
for the year, and a set of amino acid substitutions from the
dominant sequence to the sequence of the Leading Bud was
presented as predicted substitutions. After the prediction was
made, the predicted substitutions were compared by the actual
amino acid substitutions that occurred in the next year. Recall was
calculated as the number of correctly predicted substitutions
divided by the total number of actual substitutions. Precision was
calculated as the number of correctly predicted substitutions
divided by the total number of predicted amino acid substitutions.
Supporting Information
Figure S1 Scatter diagram of numbers of different
amino acids vs. corresponding distances in the 3D
map. For every pair of two sequences, the actual numbers of
different amino acids (X-axis) were plotted against corresponding
distances in the 3D map (Y-axis). Horizontal bars show the mean
values, and vertical lines indicate 61SD of distances in the 3D
map.
(EPS)
Figure S2 Three-dimensional map of the human H1N1
influenza A viruses. A total of 1228 amino acid sequences of
the HA1 domain of human H1N1 influenza A viruses isolated
during 1918 to 2010 are visualized in the 3D space. Each point
represents an HA sequence, colour-coded by the isolation year of
the virus. The whole coordination is determined by MDS analysis.
All three axes represent sequence dissimilarity (spacing between
grid lines represents 10 different amino acids), and the configu-
ration can be freely rotated and translated. Shadows represent
projections of points on a coordinate plane. Bold arrows on the
left, middle, and right indicate a seasonal H1N1 virus isolated in
2009, the pandemic H1N1 virus in 1918, and the pandemic H1N1
virus in 2009, respectively.
(EPS)
Figure S3 Boot strap resampling analysis of the mean
substitution frequency on the trunk. A total of 100
bootstrap datasets obtained were generated by random resampling
of the original 91 trunk sequences. Errors on the mean number of
different amino acids were estimated to be around one amino acid.
A curve using the formula d~328|(1{(a=(az  r rt))
a) is super-
imposed (a=0.129,   r r=0.0118).
(EPS)
Table S1 The amino acid positions that were substitut-
ed one or more time. The positions on HA where amino
amino acid substitution were occurred on the trunk are shown
with their frequency. Each alphabet represents the antigenic
domain to which the position belongs.
(DOC)
Table S2 Selected Leading Buds, predicted substitu-
tions, and actual substitutions in the retrospective tests.
Correctly predicted substitutions are shown in bold-face. The
predicted substitutions that did not occur in the next years but
occurred 2 or 3 years later are underlined. Different amino acids
on HA between a new WHO vaccine strain and preceding vaccine
strain are shown in the rightmost column.
(DOC)
Table S3 The HA sequences located near the main
trunk.
(DOC)
Movie S1 Movie of 3D map of HA sequences of H3N2
human influenza A viruses.
(MP4)
Movie S2 Movie of 3D map of HA sequences of H1N1
human influenza A viruses.
(MP4)
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